❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ News archive

Institute Seminar - Wednesday May 9th Tor Erik Rusten

The institute seminar on Wednesday May 9th will be held by Tor Erik Rusten from the Department of Biochemistry.

Title of his talk: Unraveling tumor suppressor and oncogene functions using Drosophila and human organoid modelsi

Time and place: 12.00, Auditorium, new research building, Montebello.

Links

Tor Erik Rusten's project group - Phosphatidylinositol signaling & disease

Institute Seminar overview, spring 2012 (NB - updated)

 
Scroll to top

Home Cancer Medicine Institute for Cancer Research

  • Dept. of Cancer Genetics
  • Dept. of Cancer Immunology
  • Dept. of Molecular Cell Biology
  • Dept. of Molecular Oncology
  • Dept. of Radiation Biology
  • Dept. of Tumor Biology
  • Dept. of Core Facilities
  • Institute employees
  • Dept./group overview
  • Publications
  • Institute administration
  • Annual reports
  • Institute seminars
  • Vacant positions
  • News archive
  • Scientific Advisory Board
  • ehåndbok/HES procedures

Recent publications

From major journals, first or last author from the Institute for Cancer Research

Kournoutis A, Stenmark H (2026)
Sealing and healing: A two-step model for plasma membrane repair
Dev Cell, 61 (7), 1345-1346
DOI 10.1016/j.devcel.2026.06.011, PubMed 42419281

Kleinauskas A, Canonaco M, Raabe TTH, Ryan E, Juzenas P, Grallert B, Valiraki A, Papakyriakou A, Theodossiou TA (2026)
Phenazine Methosulfate Rewires Mitochondrial Redox Circuits to Restore Membrane Potential and ATP Synthesis Under ETC Blockade in Glioblastoma Cells
Antioxidants (Basel), 15 (6)
DOI 10.3390/antiox15060749, PubMed 42352055

Panagopoulos I, Stranger A, Sveen A, Jareid M, Kidd SG, Bischof K, Taskén K, Dørum A, Davidson B, Lothe RA, Skotheim RI, Johannessen B (2026)
Fusion gene heterogeneity and kinase enrichment in high-grade serous carcinomas
Neoplasia, 79, 101332 (in press)
DOI 10.1016/j.neo.2026.101332, PubMed 42349107

More selected publications

Most recent publications

Poissonnier A, Rugo HS, Horton W, Kim T, DeLuca A, Egeland EV, Cotechini T, Sivagnanam S, Mori M, Yu Y, Park B, Beelen N, Murugan D, Kirchberger N, Kummar S, Mayer IA, Blackwell K, Hwang ES, Coussens LM (2026)
CSF1R Inhibition with Chemotherapy Relieves Systemic Immune Suppression in Patients with Metastatic Triple-Negative Breast Cancer and Boosts Anti-PD-1 Efficacy in Transgenic Mammary Tumors
Clin Cancer Res, 32 (14), 2832-2849
DOI 10.1158/1078-0432.CCR-25-4236, PubMed 41894563

De Nicolo A, Eccles DM, Aaltonen K, Alhopuro P, Ariansen SL, Biancolella M, Caputo SM, Caron O, Cavalli P, Chiang J, Claes KBM, Cuaresma ECS, de la Hoya M, De Pauw A, Díez O, Domínguez-Valentin M, Ehrencrona H, Fjeldvær MK, Fostira F, Francia MBD, Galego-Carro J, Gómez García EB, Hassan NT, Hauke J, Hirasawa A et al. (2026)
Updated ENIGMA recommendations for reporting germline variants in cancer susceptibility genes and their translation into twenty languages
J Med Genet (in press)
DOI 10.1136/jmg-2026-111498, PubMed 42135054

Nagel R, Kochavi A, Flem-Karlsen K, Adhikary M, Gal-On Y, Klaoudatou MG, Champagne J, Valcanover L, Palashati H, Nielsen MM, Feng X, Körner PR, Giebel L, Yang W, Velds A, Hoekman L, Bleijerveld OB, van Tellingen O, Olweus J, Agami R (2026)
Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope Production
Cancer Res, 86 (14), 3480-3501
DOI 10.1158/0008-5472.CAN-25-4773, PubMed 42095547

More publications

Annual summary of publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)